Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet - excipient ingredients: crospovidone; lactose monohydrate; povidone; stearic acid; colloidal anhydrous silica; microcrystalline cellulose - meniere?s syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - betahistine dihydrochloride, quantity: 8 mg - tablet - excipient ingredients: stearic acid; crospovidone; colloidal anhydrous silica; povidone; lactose monohydrate; microcrystalline cellulose - meniere?s syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus

Singapore - English - HSA (Health Sciences Authority)

goldplus universal pte ltd - betahistine dihydrochloride - tablet - betahistine dihydrochloride 24mg

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - betahistine dihydrochloride - tablet - 16 milligram(s) - antivertigo preparations; betahistine

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - betahistine dihydrochloride - tablet - 8 milligram(s) - antivertigo preparations; betahistine

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

arrow generics ltd - betahistine dihydrochloride - oral tablet - 16mg

Australia - English - Department of Health (Therapeutic Goods Administration)

southern xp ip pty ltd - betahistine dihydrochloride, quantity: 24 mg - tablet - excipient ingredients: lactose monohydrate; maize starch; microcrystalline cellulose; citric acid; povidone; crospovidone; hydrogenated vegetable oil - meniere's syndrome as defined by the following core symptoms: vertigo (with nausea/ vomiting); hearing loss (hardness of hearing); tinnitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern xp ip pty ltd - betahistine dihydrochloride, quantity: 24 mg - tablet - excipient ingredients: lactose monohydrate; maize starch; microcrystalline cellulose; citric acid; povidone; crospovidone; hydrogenated vegetable oil - meniere's syndrome as defined by the following core symptoms: vertigo (with nausea/ vomiting); hearing loss (hardness of hearing); tinnitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - betahistine dihydrochloride, quantity: 8 mg - tablet - excipient ingredients: povidone; stearic acid; lactose monohydrate; crospovidone; microcrystalline cellulose; colloidal anhydrous silica - meniere?s syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - betahistine dihydrochloride, quantity: 8 mg - tablet - excipient ingredients: lactose monohydrate; stearic acid; povidone; crospovidone; microcrystalline cellulose; colloidal anhydrous silica - meniere?s syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus